Adjuvant Imatinib Mesylate After Resection of Localised, Primary Gastrointestinal Stromal Tumour: A Randomised, Double-Blind, Placebo-Controlled Trial

The Lancet - United Kingdom
doi 10.1016/s0140-6736(09)60500-6
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

OP0208 a Proof-Of-Concept Double-Blind Randomised Placebo-Controlled Trial of Probiotics in Systemic Sclerosis Associated Gastrointestinal Disease

2018English

CCR5 Blockade in Rheumatoid Arthritis: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2010English

Randomised, Double-Blind, Placebo-Controlled Trial of EPs 7630 in Adults With COPD

Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Sunitinib Malate for Gastrointestinal Stromal Tumour in Imatinib Mesylate–resistant Patients: Recommendations and Evidence

Current Oncology
Oncology
2010English

Tranexamic Acid Reduces Blood Loss After Primary Shoulder Arthroplasty: A Double-Blind, Placebo-Controlled, Prospective, Randomized Controlled Trial

JSES Open Access
2018English

Photodynamic Therapy for Dysplastic Barrett's Oesophagus: A Prospective, Double Blind, Randomised, Placebo Controlled Trial

Gut
Gastroenterology
2000English

TRYMS: The Ethical and Practical Considerations of a Double-Blind Placebo Controlled Randomised Clinical Trial

Trials
MedicinePharmacology
2015English

Limited Effect of Sulphasalazine Treatment in Reactive Arthritis. A Randomised Double Blind Placebo Controlled Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1997English

Primary Prostatic Extra-Gastrointestinal Stromal Tumor Treated With Imatinib Mesylate as Neoadjuvant and Adjuvant Therapy: A Case Report and Literature Review

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy